US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist

0.272
-0.006-2.16%

Close Aug 23 16:00 ET

0.271
-0.001-0.40%

Post 19:46 ET

4.70MMarket Cap-110P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

17.99%5.11M

-32.16%3.26M

5.37%18.5M

-21.13%4.03M

23.30%5.3M

-7.24%4.33M

38.55%4.81M

198.89%17.55M

82.78%5.11M

84.63%4.3M

Selling and administrative expenses

-5.78%2.03M

-33.37%1.53M

-14.84%7.15M

-75.24%695.41K

3.95%1.98M

3.34%2.16M

43.89%2.3M

147.31%8.4M

65.15%2.81M

39.69%1.91M

-General and administrative expense

-5.78%2.03M

-33.37%1.53M

-14.84%7.15M

-75.24%695.41K

3.95%1.98M

3.34%2.16M

43.89%2.3M

147.31%8.4M

65.15%2.81M

39.69%1.91M

Research and development costs

3.90%3.08M

-32.12%1.76M

19.85%12.26M

25.19%3.36M

9.81%3.34M

13.20%2.97M

37.72%2.59M

271.55%10.23M

109.00%2.69M

206.56%3.04M

Other operating expenses

----

65.93%-27.06K

14.57%-923.04K

92.90%-27.25K

95.81%-27.44K

-2,171.63%-788.94K

-1,036.04%-79.41K

-288.18%-1.08M

-102.47%-383.77K

-1,963.81%-654.95K

Operating profit

-17.99%-5.11M

32.16%-3.26M

-5.37%-18.5M

21.13%-4.03M

-23.30%-5.3M

7.24%-4.33M

-38.55%-4.81M

-198.89%-17.55M

-82.78%-5.11M

-84.63%-4.3M

Net non-operating interest income expense

43.35%-4.3K

-10.15%-9.54K

-337.23%-50.61K

-149.49%-55.76K

-98.54%131

-670.77%-7.6K

-2,059.05%-8.66K

87.74%-11.58K

-4,482.35%-22.35K

4,788.02%9K

Non-operating interest income

-27.64%178

-96.48%168

-74.11%5.29K

-98.58%137

-98.54%131

-81.52%246

979.19%4.77K

2,973.80%20.41K

1,789.41%9.64K

6,283.69%9K

Non-operating interest expense

-42.85%4.48K

-27.72%9.71K

74.76%55.9K

----

--7.84K

--13.43K

-66.36%31.99K

----

Other net income (expense)

-72.59K

-55.35K

Gain on sale of security

---72.59K

---55.35K

----

Income before tax

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

Income tax

Net income

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

Net income continuous Operations

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

Minority interest income

Net income attributable to the parent company

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

Basic earnings per share

99.48%-0.74

99.75%-0.65

90.43%-103.61

97.94%-6.5146

74.58%-67.2

50.56%-142.38

-19.94%-259.07

-67.10%-1.08K

-82.31%-316.39

-65.25%-264.4

Diluted earnings per share

99.48%-0.74

99.75%-0.65

90.43%-103.61

97.94%-6.5146

74.58%-67.2

50.56%-142.38

-19.94%-259.07

-67.10%-1.08K

-82.31%-316.39

-65.25%-264.4

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	17.99%5.11M	-32.16%3.26M	5.37%18.5M	-21.13%4.03M	23.30%5.3M	-7.24%4.33M	38.55%4.81M	198.89%17.55M	82.78%5.11M	84.63%4.3M
Selling and administrative expenses	-5.78%2.03M	-33.37%1.53M	-14.84%7.15M	-75.24%695.41K	3.95%1.98M	3.34%2.16M	43.89%2.3M	147.31%8.4M	65.15%2.81M	39.69%1.91M
-General and administrative expense	-5.78%2.03M	-33.37%1.53M	-14.84%7.15M	-75.24%695.41K	3.95%1.98M	3.34%2.16M	43.89%2.3M	147.31%8.4M	65.15%2.81M	39.69%1.91M
Research and development costs	3.90%3.08M	-32.12%1.76M	19.85%12.26M	25.19%3.36M	9.81%3.34M	13.20%2.97M	37.72%2.59M	271.55%10.23M	109.00%2.69M	206.56%3.04M
Other operating expenses	----	65.93%-27.06K	14.57%-923.04K	92.90%-27.25K	95.81%-27.44K	-2,171.63%-788.94K	-1,036.04%-79.41K	-288.18%-1.08M	-102.47%-383.77K	-1,963.81%-654.95K
Operating profit	-17.99%-5.11M	32.16%-3.26M	-5.37%-18.5M	21.13%-4.03M	-23.30%-5.3M	7.24%-4.33M	-38.55%-4.81M	-198.89%-17.55M	-82.78%-5.11M	-84.63%-4.3M
Net non-operating interest income expense	43.35%-4.3K	-10.15%-9.54K	-337.23%-50.61K	-149.49%-55.76K	-98.54%131	-670.77%-7.6K	-2,059.05%-8.66K	87.74%-11.58K	-4,482.35%-22.35K	4,788.02%9K
Non-operating interest income	-27.64%178	-96.48%168	-74.11%5.29K	-98.58%137	-98.54%131	-81.52%246	979.19%4.77K	2,973.80%20.41K	1,789.41%9.64K	6,283.69%9K
Non-operating interest expense	-42.85%4.48K	-27.72%9.71K	74.76%55.9K	----	----	--7.84K	--13.43K	-66.36%31.99K	----	----
Other net income (expense)	-72.59K	-55.35K
Gain on sale of security	---72.59K	---55.35K	----	----	----	----	----	----	----	----
Income before tax	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M
Income tax
Net income	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M
Net income continuous Operations	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M
Minority interest income
Net income attributable to the parent company	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M
Basic earnings per share	99.48%-0.74	99.75%-0.65	90.43%-103.61	97.94%-6.5146	74.58%-67.2	50.56%-142.38	-19.94%-259.07	-67.10%-1.08K	-82.31%-316.39	-65.25%-264.4
Diluted earnings per share	99.48%-0.74	99.75%-0.65	90.43%-103.61	97.94%-6.5146	74.58%-67.2	50.56%-142.38	-19.94%-259.07	-67.10%-1.08K	-82.31%-316.39	-65.25%-264.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall